Benchsci.com Website Review

let our ai decode the literature to provide antibody usage data that's unbiased and experiment-specific. in partnership with the world's leading scientific publishers. backed by google’s ai fund, benchsci is trusted by over 1,300 academic institutions and 15 of the top 20 pharmaceutical companies. reduce the time, uncertainty, and cost of selecting and purchasing antibodies for your experiments. leverage machine learning technology to decode antibody usage data in millions of open- and closed-access papers search by protein and filter by technique and 15 other options to scan the literature faster see published figures with no commercial bias to select antibodies with confidence leverage machine learning technology to decode antibody usage data in millions of open- and closed-access papers search by protein and filter by technique and 15 other options to scan the literature faster see published figures with no commercial bias to select antibodies with confidence. see what customers, partners, and media say about benchsci's impact. alphabet's ai venture capital firm makes first investment in canada with benchsci dr. david rimm on antibodies, reproducibility, and benchsci benchsci is the right step towards a better antibody selection process. whenever we need antibodies, we start with benchsci.